ICU Medical holders approve 2,150,000-share plan increase and elect all seven directors
At its annual meeting on May 13, 2025, ICU Medical stockholders approved a third amendment to the 2011 Stock Incentive Plan, raising the total shares available for issuance to 8,515,510 and the incentive stock option limit by the same 2,150,000 shares. Stockholders also elected all seven director nominees and ratified Deloitte & Touche LLP as the independent auditor for fiscal 2025.
Key points
- Plan amendment adds 2,150,000 shares, bringing the aggregate to 8,515,510 shares of common stock; the incentive stock option limit rises by the same amount.
- All seven director nominees were elected, including Vivek Jain with 21,022,893 votes for and 550,209 withheld.
- Advisory simple majority voting proposal passed with 18,429,634 votes for and 3,094,805 against.
- Deloitte & Touche LLP was ratified for the fiscal year ending December 31, 2025, with 22,516,651 votes for and 1,165,480 against.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:01 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 14, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.